Cargando…
Pharmaco-economic evaluation of antibiotic therapy strategies in DRG-based healthcare systems - a new approach
The cost of treatments especially in conditions where multiresistant bacteria are involved are a major issue in times where in most developed countries in the world payment systems based on diagnoses-related-groups (DRG) are in place. There is great evidence that especially the length of stay in hos...
Autores principales: | Wilke, MH, Grube, R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352105/ https://www.ncbi.nlm.nih.gov/pubmed/21163731 http://dx.doi.org/10.1186/2047-783X-15-12-564 |
Ejemplares similares
-
The use of a standardized PCT-algorithm reduces costs in intensive care in septic patients - a DRG-based simulation model
por: Wilke, MH, et al.
Publicado: (2011) -
CHEERS to 30 Years of PharmacoEconomics
por: Milne, Richard, et al.
Publicado: (2021) -
Guideline-adherent initial intravenous antibiotic therapy for hospital-acquired/ventilator-associated pneumonia is clinically superior, saves lives and is cheaper than non guideline adherent therapy
por: Wilke, MH, et al.
Publicado: (2011) -
Botulinum toxin as treatment for focal dystonia: a systematic review of the pharmaco-therapeutic and pharmaco-economic value
por: Zoons, E., et al.
Publicado: (2012) -
ArrhythmoGenoPharmacoTherapy
por: Tosaki, Arpad
Publicado: (2020)